This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Varian's (VAR) ProBeam System Gets Picked by Delray Medical
by Zacks Equity Research
Varian Medical's (VAR) coveted ProBeam platform sees a slew of developments; market prospects solid.
Here's Why You Should Hold on to Abiomed (ABMD) for Now
by Zacks Equity Research
Abiomed's (ABMD) margin continues to remain pressed; an upbeat view for fiscal 2019 encourages.
Quality Systems Ties Up With CoverMyMeds to Enable ePA
by Zacks Equity Research
Quality Systems' (QSII) new collaboration with CoverMyMeds sees bright market prospects.
What Falling Estimates & Price Mean for Computer Programs and Systems (CPSI)
by Zacks Equity Research
Computer Programs and Systems (CPSI) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Zacks.com featured highlights include: Columbia Sportswear, Illumina, WellCare, athenahealth and Caterpillar
by Zacks Equity Research
Zacks.com featured highlights include: Columbia Sportswear, Illumina, WellCare, athenahealth and Caterpillar
athenahealth (ATHN) Up 2.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
athenahealth (ATHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Top Stocks Likely to Beat Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
Zacks.com highlights: athenahealth, Commvault Systems, Molina Healthcare and Fortinet
by Zacks Equity Research
Zacks.com highlights: athenahealth, Commvault Systems, Molina Healthcare and Fortinet
4 Top Liquid Stocks for a Winning Portfolio
by Zacks Equity Research
Here are four marvelous liquid stocks that investors should snap up now for stellar returns.
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Banner, Amazon.com, BJ's, athenahealth and BioTelemetry
Allscripts' Payerpath & ePrescribe Receive EHNAC Accreditation
by Zacks Equity Research
Accreditation by EHNAC indicates Allscripts' (MDRX) sustainability in health data processing and transactions in terms of industry-established standards and HIPAA regulations.
Bull Run Set to Become the Longest in History: 5 Winners
by Tirthankar Chakraborty
The current bull market in U.S. stocks is about to become the longest on record, and optimistic analysts are predicting that it has miles to go before it rests.
athenahealth Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
athenahealth has been struggling lately, but the selling pressure may be coming to an end soon.
Pacific Biosciences' Sequel Sees Solid Q2, Competition Rife
by Zacks Equity Research
Pacific Biosciences (PACB) gains from solid presence in Asia; competition likely to mar results.
Allscripts Sunrise Picked by UK's Maidstone and Tunbridge Wells
by Zacks Equity Research
Allscripts' (MDRX) Sunrise platform witnesses a suite of developments, fortifying the company's global foothold.
athenahealth (ATHN) Beats on Q2 Earnings, Raises '19 View
by Zacks Equity Research
An upbeat 2018 guidance instills investor's optimism for athenahealth (ATHN). However, lackluster performance in the Implementation and other segment is a persistent headwind.
What's in Store for Cardinal Health (CAH) in Q4 Earnings?
by Zacks Equity Research
Cardinal Health (CAH) is likely to witness solid growth in the core Pharmaceutical segment in Q4 results. However, lackluster performance in the Cordis unit is likely to mar prospects.
Can Business Services Aid athenahealth's (ATHN) Q2 Earnings?
by Zacks Equity Research
athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.
3 Undervalued MedTech Stocks to Stay Safe From Trade War
by Sreyoshi Mukherjee
Amid U.S. market turmoil, a few stocks from the MedTech industry can prove profitable over the long haul.
Patterson's (PDCO) NaVetor Launch to Boost Animal Health Unit
by Zacks Equity Research
Patterson Companies (PDCO) collaborates with Cure Partners to form a new business; launches NaVetor for Animal Health Unit.
ResMed Inks Deal With athenaHealth on Brightree's eReferral
by Zacks Equity Research
ResMed's (RMD) wholly owned unit Brightree remains integral to the company's group for two full years with a consistent stretch of success.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Minor Econ Metrics Pave the Way Forward
by Mark Vickery
Productivity and Unit Labor Costs, as well as a new Trade Deficit for April, are claiming a few headlines this morning.
Why is athenahealth (ATHN) Up 7.3% Since Its Last Earnings Report?
by Zacks Equity Research
athenahealth (ATHN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ecolab (ECL) Rolls Out HDI for Improved Food Surveillance
by Zacks Equity Research
Ecolab's (ECL) launches HDI platform to provide insights into better food safety management.